InVivo Therapeutics RAPID INTERVENTIONPIONEERING TECHNOLOGY Redefining the treatment of spinal cord injury PATIENTS LEARN MORE ABOUT SPINAL CORD INJURY TREATMENT AND RECOVERY TECHNOLOGY LEARN HOW OUR TECHNOLOGY IS DESIGNED TO SUPPORT CELL SURVIVAL AND GROWTH NEWS READ OUR LATEST UPDATES © 2021 INVIVO THERAPEUTICS PRIVACY POLICY TERMS OF SERVICE

Skip to main navigation InVivo Therapeutics Presentations November 2021 Corporate Presentation November 12, 2021 The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the InVivo website for historical purposes only. InVivo assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates. Invivo - Investor Tools Print Page Email Alerts RSS Feeds Contact IR © 2021 INVIVO THERAPEUTICS Invivo - Site Footer Menu PRIVACY POLICY TERMS OF SERVICE SUBSCRIBE TWITTER FACEBOOK LINKEDIN

InVivo Therapeutics OUR MISSION AND VISION At InVivo, we are focused on redefining the treatment of spinal cord injury. By modulating the healing environment to facilitate cell survival and growth, we have the opportunity to change the treatment of spinal cord injury. We have steadily advanced our scaffold technology through years of research and development with encouraging clinical data. Our team is united in our commitment to bring the Neuro-Spinal Scaffold™ to patients and to deliver meaningful improvements to their daily lives. WE ARE COMMITTED UNRELENTING PERSISTENT We are committed to the patients who have had their lives forever changed by spinal cord injury. Our Leadership Richard Toselli, M.D. PRESIDENT, CHIEF EXECUTIVE OFFICER AND CHIEF MEDICAL OFFICER DIRECTOR Richard Christopher CHIEF FINANCIAL OFFICER William D’Agostino SENIOR VICE PRESIDENT, OPERATIONS Heather Hamel VICE PRESIDENT, LEGAL AFFAIRS AND BUSINESS DEVELOPMENT CORPORATE SECRETARY Board of Directors Ann Merrifield CHAIR OF THE BOARD Daniel R. Marshak, Ph.D. Christina Morrison Sir Richard J. Roberts, Ph.D., F.R.S. Robert J. Rosenthal, Ph.D. Richard Toselli, M.D. Scientific Advisory Board Robert S. Langer, Sc.D. Sir Richard J. Roberts, Ph.D., F.R.S. James Guest, M.D., Ph.D. V. Reggie Edgerton, Ph.D. Contact Address: One Kendall Square, Building 1400 West, Floor 4, Cambridge, MA 02139 Phone: 617-863-5500 Email: investor-relations@invivotherapeutics.com © 2021 INVIVO THERAPEUTICS PRIVACY POLICY TERMS OF SERVICE